TruDiagnostic TruAge vs NOVOS Age: Which Is Better in 2026?

If scientific rigor is your priority, TruDiagnostic TruAge ($299) is the clearer choice. It runs validated epigenetic clocks (Horvath, DunedinPACE, and GrimAge), and its DunedinPACE pace-of-aging metric is uniquely useful for tracking whether an intervention is measurably slowing how fast you age. It is also, notably, cheaper than NOVOS Age ($349) while going deeper on the methylation science. The tradeoffs are real: TruAge takes 4 to 6 weeks to return results, and the multi-clock output takes effort to interpret. NOVOS Age is the friendlier option; it folds an epigenetic clock together with telomere length and a facial skin-age scan into an approachable snapshot tied to an actionable longevity plan, which beginners often prefer. So the honest split: pick TruAge if you want the most validated, research-grade reading and will sit with the complexity; pick NOVOS if accessibility, faster gratification, and a done-for-you plan matter more than clock precision. Either way, no biological-age test is proven to forecast your lifespan. Track your own trend across repeat tests rather than fixating on one number.

Both are epigenetic (DNA-methylation) tests, but they aim at different users. TruAge is the research-grade option: it reports multiple validated clocks, including Horvath, GrimAge, and crucially DunedinPACE, which estimates your current pace of aging rather than a static age. That pace metric is what makes TruAge genuinely useful for judging whether a longevity protocol is doing anything. NOVOS Age is the multi-metric consumer option, blending a methylation clock with telomere length and a facial skin-age scan into one digestible readout.

On experience, TruAge trades speed and simplicity for depth; results take 4 to 6 weeks and reward some interpretive effort. NOVOS trades some scientific precision for an app-driven, plan-attached flow that beginners find easier to act on. Cost slightly favors TruAge. As always in this category, single readings can wobble for reasons unrelated to real aging, so both are best used as trend trackers across repeat tests.

Choose TruDiagnostic TruAge if you want the most scientifically validated reading, care about tracking your pace of aging via DunedinPACE, and are comfortable waiting 4 to 6 weeks and interpreting multi-clock results. It is the better instrument for serious self-experimenters testing whether an intervention works.

Choose NOVOS Age if you are newer to biological-age testing and value an approachable, multi-signal snapshot with a ready-made longevity plan over maximum clock precision.

Choose either as a repeat tool, not a one-off; a single number means little without a trend to compare it against.

Honest tradeoff: the field is still maturing. Even the best consumer epigenetic clocks can vary between tests, and none has been proven to predict how a given intervention changes your lifespan. TruAge gives you more rigor and a pace metric; NOVOS gives you accessibility and guidance. Decide which you will actually use consistently, because consistency, not the specific brand, is what makes these tests informative.